FDA's Legislative Request on Rx and Compounded Drug Advertising Coalition for Healthcare Communication September 8, 2025: FDA launches an import alert listing safe GLP 1 manufacturers Partnership for Safe Medicines Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York